3 Potential “Game-Changer” Biotech Stocks With Triple-Digit Upside Potential

2020-05-08 20_58_20-Unrecognizable chemist taking liquid with pipette from test tube in modern labor“Veteran players of the stock picking game know that biotechs are capable of delivering a win at what feels like the drop of a hat,” notes the author of today’s article, who proceeds to highlight three biotech stocks, identified by investment firm Wedbush, with the potential to be game-changers. For these three Buy-rated biotech stocks with triple-digit upside potential, CLICK HERE.

Read More

Ahead Of Q1 Earnings, Goldman Sachs Is Bullish On These 4 Biotech Stocks

2020-04-30 20_38_05-woman holding laboratory appratus photo – Free Public health Image on UnsplashWith all the attention the top-performing health care sector, and biopharmaceutical stocks in particular, are receiving, which biotech stocks are worth a look ahead of their first-quarter earnings reports? Analysts at Goldman Sachs have identified four that they are bullish on, and today’s article notes that “While their shares only suited for aggressive growth accounts with a high-risk profile, none of these companies is a proverbial one-trick pony. In addition, they all are potential takeover candidates.” For more, CLICK HERE.

Read More

Ultra Risk Could Lead To Ultra Riches With These 3 Biotech Stocks

2020-04-23 21_33_04-WindowWhen it comes to the three clinical-stage biotech stocks highlighted in today’s article, the author declares that, while they are all “relatively small at the moment…they have potential blockbuster drugs in development that could send their stock prices screaming higher.” For these three biotech stocks whose ultra risk could lead to ultra riches with clinical trial success, CLICK HERE.

Read More

3 Market-Beating Biotech Stocks With More Room To Run – Including One “Oddball” Pick

2020-04-12 20_10_12-person holding round clear container photo – Free Science Image on UnsplashBiotech stocks have weathered the coronavirus selloff pretty well on the whole – and today’s article notes that “Several biotechs have delivered solid gains in the midst of the overall stock market plunge.” For three top biotech stock picks that have been beating the market and that still have lots of room to run from here – including one “oddball” biotech pick that has no approved products on the market and no profits but does have a potential vaccine for COVID-19 and a potential blockbuster flu vaccine – CLICK HERE.

Read More